Today's Markets 5-Minute Digest (2026.07.09)

Markets took fresh US-Iran strikes largely in stride, with Nasdaq and S&P 500 futures rising as attention swung back to AI and the chip trade. Underneath the calm, earnings were mixed (PepsiCo missed, Levi beat, AstraZeneca cratered on a failed trial) while Fed minutes flagged growing inflation concerns.

1. US-Iran strikes: futures rise, gold slips, IMF sees 3% growth

Source: Trump says Iran called to make a deal after U.S. strikes; ad (click for the original)

Trump said Iran called to make a deal after US strikes but added it is unclear whether war resumes. Equity futures rose as investors 'took Mideast tensions in stride,' and gold opened lower even as airstrikes continued.

The IMF projected the world economy to grow a sluggish 3% this year, weighed down by the Iran war but supported by AI.

Watch whether the diplomatic signal holds and how oil, gold and Hormuz shipping headlines evolve; a shift from 'contained' to 'escalating' would test the market's current composure.

• Trump says Iran called to make a deal after U.S. strikes; adds it's unclear if war is back on
• Stock Market Today: Nasdaq Futures Gain as Investors Take Mideast Tensions in Stride
• IMF expects world economy to grow a sluggish 3% this year, weighed down by Iran war but helped by AI

2. Earnings: AstraZeneca -9% on trial miss, PepsiCo misses, Levi raises guidance

Source: AstraZeneca stock drops 9% after heart drug trial miss deals (click for the original)

AstraZeneca shares dropped about 9% after a heart-drug trial miss, a rare setback that MarketWatch tied to roughly $27 billion in lost market value. PepsiCo's Q2 2026 earnings missed as North American consumers tightened budgets; revenue beat but EPS missed, and snack price cuts have not driven US growth.

On the upside, Levi Strauss beat quarterly expectations and raised guidance and its dividend, while Nike's management stayed cautious despite an earnings beat.

Consumer names point to soft US demand and pricing pressure; the AstraZeneca drop shows how binary clinical readouts can be. Watch guidance tone and North American volumes into the rest of earnings season.

• AstraZeneca stock drops 9% after heart drug trial miss deals rare blow to pharma powerhouse
• PepsiCo earnings miss estimates as North American consumers tighten their budgets
• Levi Strauss beats quarterly expectations, raises guidance and dividend

3. AI capex: Meta's Canada data center, Apple's $30B Broadcom deal, SambaNova at $11B

Source: Meta is building its first big Canadian data center as AI ex (click for the original)

Big Tech kept spending on AI: Meta said it will build its first large data center in Canada, expanding its global fleet, while Apple plans to spend $30 billion on Broadcom chips as it boosts US sourcing. AI chip startup SambaNova reached an $11 billion valuation after closing a $1 billion Series F.

Yahoo Finance coverage noted Nvidia's stock is unusually cheap despite an on-track AI roadmap, alongside pieces questioning Microsoft's, Salesforce's and Oracle's AI investments and returns.

Spending commitments remain large, but several write-ups question payback and valuations. Watch capex disclosures, chip supplier concentration (e.g., Broadcom, Nvidia) and whether AI revenue keeps pace with buildout.

• Meta is building its first big Canadian data center as AI expansion crosses the border
• Apple to spend $30 billion on Broadcom chips as it boosts US sourcing
• SambaNova reaches $11bn valuation in $1bn Series F close

4. Chip trade: SK Hynix's oversubscribed US listing, KOSPI in bear territory

Source: Meet SK Hynix, the trillion-dollar South Korean chipmaker de (click for the original)

SK Hynix, the trillion-dollar South Korean chipmaker, is debuting on US markets, and its US listing was reportedly more than seven times oversubscribed. Yahoo Finance flagged the IPO as 'a crucial test for the chip trade' landing Friday.

At the same time, CNBC reported that KOSPI — this year's best-performing market — fell into bear territory amid questions around AI, Samsung and chipmakers, while AirPods-maker Luxshare closed lower in a tepid Hong Kong debut.

SK Hynix's US debut is a live gauge of appetite for the chip trade; strong demand and weak secondary-market debuts (Luxshare) send mixed signals. Watch pricing, first-day trading and read-through to Samsung and Korean chip sentiment.

• Meet SK Hynix, the trillion-dollar South Korean chipmaker debuting on U.S. markets
• SK Hynix's US listing more than seven times oversubscribed, source says
• Why the world's best-performing stock market this year fell into bear territory

5. Macro & rates: Fed minutes flag inflation, dollar buffer 'fading'

Source: Fed policymakers' inflation concerns grew at June meeting, m (click for the original)

Minutes from the June meeting showed Fed policymakers' inflation concerns grew, per Reuters. MarketWatch warned that a historic bond-market buffer that protected the US dollar is fading, and reported Schwab strategists saying the era of easy index gains is 'officially over.'

Separately, USA Today noted workers keep leaving the US labor force, with experts split on why — a data point for the growth-and-participation debate.

These are variables to watch, not directional calls: the inflation tone in Fed communications, dollar behavior versus bonds, and labor-force participation. A hawkish reading could pressure rate-cut expectations.

• Fed policymakers' inflation concerns grew at June meeting, minutes show
• A warning for the U.S. dollar: The historic bond-market buffer that protected the currency is fading.
• Schwab strategists warn of a major market shift: The era of easy index gains is officially over

Disclaimer: This content is for informational purposes only and is not investment advice. Investment decisions are your own responsibility.
This digest summarizes the past 24 hours of news from public RSS feeds. See the linked sources for details.